Skip to content
  • About
    • Mission & Values
    • Leadership
    • Strategic Partners
    • Corporate Governance
    • Careers
    • Mission & Values
    • Leadership
    • Strategic Partners
    • Corporate Governance
    • Careers
  • Drug Development
    • Our Approach
    • Advantages
    • The Process
    • Approval Pathways
    • Why We’re The Experts
    • Our Approach
    • Advantages
    • The Process
    • Approval Pathways
    • Why We’re The Experts
  • Product
    • Transforming Molecules
    • Current Products
    • A Growing Portfolio
    • IP & Patents
    • Trademarks
    • Transforming Molecules
    • Current Products
    • A Growing Portfolio
    • IP & Patents
    • Trademarks
  • PPS
    • OA
    • MPS VI
    • MPS I
    • HF
    • ARDS
    • CHIKV/RRV
    • AR
    • OA
    • MPS VI
    • MPS I
    • HF
    • ARDS
    • CHIKV/RRV
    • AR
  • Investor
  • Resources
    • Upcoming Events
    • Shifts In Thinking
    • Peer-Reviewed Publications
    • In the Media
    • Media Archive
    • Upcoming Events
    • Shifts In Thinking
    • Peer-Reviewed Publications
    • In the Media
    • Media Archive
Cancel
Contact
Contact
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Presentations
  • Product Developments
  • Development Pipeline
  • Clinical Trials
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Presentations
  • Product Developments
  • Development Pipeline
  • Clinical Trials

Stay up to date

Join the Paradigm Biopharma mailing list

Partner enquiry
Investor enquiry

> dynamic-content-megamenu-menuitem11184

About Paradigm
  • Our Mission
  • Our Values
  • Belief In Transforming Medicines
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
  • Our Mission
  • Our Values
  • Belief In Transforming Medicines
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
Drug Development
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
Product Development
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP / patents
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP / patents
Pentosan Polysulfate Sodium
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI 
  • MPS I 
  • HF 
  • ARDS 
  • CHIKV/RRV 
  • AR 
  • Further Potential
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI 
  • MPS I 
  • HF 
  • ARDS 
  • CHIKV/RRV 
  • AR 
  • Further Potential
Investor
  • ASX Performance
  • ASX Announcements
  • Analyst Reports
  • Presentations
  • Product Developments
  • Development Pipeline
  • Clinical Trials
  • ASX Performance
  • ASX Announcements
  • Analyst Reports
  • Presentations
  • Product Developments
  • Development Pipeline
  • Clinical Trials
Resources
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
FAQ
Contact
  • Partner Enquiry 
  • Investor Enquiry 
  • General Enquiry
  • Partner Enquiry 
  • Investor Enquiry 
  • General Enquiry
info@paradigmbiopharma.com

Copyright © 2022 Paradigm Biopharmaceuticals Ltd. All rights reserved.

  • Privacy policy
  • Terms of use
Twitter Linkedin Facebook
Get in touch

Paradigm is always looking for people and partners
who share our vision.

Partner enquiry
Investor enquiry

Stay up to date

Join the Paradigm Biopharma mailing list

> dynamic-content-megamenu-menuitem11184

About
  • About Paradigm
  • Our Mission
  • Our Values
  • Belief In Transforming Medicines
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
  • About Paradigm
  • Our Mission
  • Our Values
  • Belief In Transforming Medicines
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
Drug Development
  • Development Experts
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
  • Development Experts
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
Product Development
  • Product Development
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP / Patents
  • Trademarks
  • Product Development
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP / Patents
  • Trademarks
Pentosan Polysulfate Sodium
  • Pentosan Polysulfate Sodium
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI 
  • MPS I 
  • HF 
  • ARDS 
  • CHIKV/RRV 
  • AR 
  • Other Indications
  • Pentosan Polysulfate Sodium
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI 
  • MPS I 
  • HF 
  • ARDS 
  • CHIKV/RRV 
  • AR 
  • Other Indications
Investor
  • Performance & Progress
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Product Developments
  • Development Pipeline
  • Clinical Trials
  • Performance & Progress
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Product Developments
  • Development Pipeline
  • Clinical Trials
Resources
  • Events & Resources
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
  • Events & Resources
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
FAQ

Repurposing FAQ

Contact
  • Partner Enquiry
  • Partner Enquiry
  • General Enquiry
  • Partner Enquiry
  • Partner Enquiry
  • General Enquiry

Copyright © 2022 Paradigm Biopharmaceuticals Ltd.
All rights reserved. info@paradigmbiopharma.com
Privacy Policy | Terms of Use

Twitter Linkedin Facebook
Contact

Cancel

QUICK LINKS
  • Pentosan Polysulfate Sodium
  • Osteoarthritis
  • ASX performance
  • Clinical trials
  • Upcoming events
About
  • About Paradigm
  • Mission & Values
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
  • About Paradigm
  • Mission & Values
  • Leadership
  • Board 
  • Executive Team 
  • Strategic Partners
  • Corporate Governance
  • Careers
Drug Development
  • Development Experts
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
  • Development Experts
  • Our Approach
  • Advantages
  • The Process
  • Approval Pathways
  • Why We’re The Experts
Product Development
  • Product Development
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP & Patents
  • Trademarks
  • Product Development
  • Transforming Molecules
  • Current Products
  • A Growing Portfolio
  • IP & Patents
  • Trademarks
Pentosan Polysulfate Sodium
  • Pentosan Polysulfate Sodium
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI
  • MPS I
  • HF
  • ARDS
  • CHIKV/RRV
  • AR
  • Other Indications
  • Pentosan Polysulfate Sodium
  • Lead Indication
  • OA 
  • Mechanism of Action
  • Safety Profile
  • Commercialisation
  • Further Indications
  • MPS VI
  • MPS I
  • HF
  • ARDS
  • CHIKV/RRV
  • AR
  • Other Indications
Investor
  • Performance & Progress
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Product Developments
  • Development Pipeline
  • Clinical Trials
  • Performance & Progress
  • Market Performance
  • ASX Announcements
  • Analyst Reports
  • Product Developments
  • Development Pipeline
  • Clinical Trials
Resources
  • Events & Resources
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
  • Events & Resources
  • Upcoming Events
  • Shifts In Thinking
  • Peer-Reviewed Publications
  • In the Media
  • Media Archive
FAQ

Repurposing FAQ

Contact
  • Partner Enquiry
  • Partner Enquiry
  • General Enquiry
  • Partner Enquiry
  • Partner Enquiry
  • General Enquiry
Some cookies are strictly necessary for the operation of our website. We also use cookies to monitor your use of our website, compile aggregate data and provide you with a good experience when browsing. You can choose to accept or reject cookies, or manage your specific cookie options. For more detailed information on what cookies are and how they work, please read our Cookies Policy.
Decline allAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.